{"effective_time":"20171205","id":"c1a3f11c-539f-422c-aa56-b95d07d7a535","openfda":{},"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL NDC 49401-104-01 RAXIBACUMAB Injection 1700 mg/34mL (50 mg/mL) For Intravenous Infusion Must be Diluted Prior To Use Rx only Single-Use Vial; Discard unused portion ATTENTION: Confirm expiration date on carton prior to removing vial. Before use apply enclosed label to vial over the existing label. 34 mL For Strategic National Stockpile Use Only 10000000115020 Rev. 3/13 Raxibacumab 34 mL vial carton","PRINCIPAL DISPLAY PANEL NDC 49401-103-01 Raxibacumab Injection 1700 mg/34mL (50 mg/mL) For Intravenous Infusion Must be Diluted Prior To Use Rx only Single-Use Vial Discard unused portion. 34 mL Rev. 11/15 10000000137037 Raxibacumab 34 mL carton"],"set_id":"bfaf55bc-06fd-4459-aea8-90cc90c1a868","spl_product_data_elements":["Raxibacumab raxibacumab RAXIBACUMAB RAXIBACUMAB CITRIC ACID MONOHYDRATE GLYCINE POLYSORBATE 80 SODIUM CITRATE, UNSPECIFIED FORM SUCROSE Raxibacumab raxibacumab RAXIBACUMAB RAXIBACUMAB CITRIC ACID MONOHYDRATE GLYCINE POLYSORBATE 80 SODIUM CITRATE, UNSPECIFIED FORM SUCROSE"],"version":"2"}